These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 29948916

  • 21. Preparation and evaluation of sustained-release matrix tablets based on metoprolol and an acrylic carrier using injection moulding.
    Quinten T, Andrews GP, De Beer T, Saerens L, Bouquet W, Jones DS, Hornsby P, Remon JP, Vervaet C.
    AAPS PharmSciTech; 2012 Dec; 13(4):1197-211. PubMed ID: 22965662
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Formulation of sustained-release dosage form of verapamil hydrochloride by solid dispersion technique using Eudragit RLPO or Kollidon SR.
    Sahoo J, Murthy PN, Biswal S, Manik.
    AAPS PharmSciTech; 2009 Dec; 10(1):27-33. PubMed ID: 19145487
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Preparation and in vitro/in vivo evaluation of gliclazide loaded Eudragit nanoparticles as a sustained release carriers.
    Devarajan PV, Sonavane GS.
    Drug Dev Ind Pharm; 2007 Feb; 33(2):101-11. PubMed ID: 17454041
    [Abstract] [Full Text] [Related]

  • 26. Sustained release from hot-melt extruded matrices based on ethylene vinyl acetate and polyethylene oxide.
    Almeida A, Brabant L, Siepmann F, De Beer T, Bouquet W, Van Hoorebeke L, Siepmann J, Remon JP, Vervaet C.
    Eur J Pharm Biopharm; 2012 Nov; 82(3):526-33. PubMed ID: 22986082
    [Abstract] [Full Text] [Related]

  • 27. Citric acid as a solid-state plasticizer for Eudragit RS PO.
    Schilling SU, Shah NH, Malick AW, Infeld MH, McGinity JW.
    J Pharm Pharmacol; 2007 Nov; 59(11):1493-500. PubMed ID: 17976259
    [Abstract] [Full Text] [Related]

  • 28. Preparation and evaluation of ketoprofen hot-melt extruded enteric and sustained-release tablets.
    Yang R, Wang Y, Zheng X, Meng J, Tang X, Zhang X.
    Drug Dev Ind Pharm; 2008 Jan; 34(1):83-9. PubMed ID: 18214759
    [Abstract] [Full Text] [Related]

  • 29. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
    Schilling SU, Bruce CD, Shah NH, Malick AW, McGinity JW.
    Int J Pharm; 2008 Sep 01; 361(1-2):158-68. PubMed ID: 18582547
    [Abstract] [Full Text] [Related]

  • 30. Development of enteric submicron particle formulation of papain for oral delivery.
    Sharma M, Sharma V, Panda AK, Majumdar DK.
    Int J Nanomedicine; 2011 Sep 01; 6():2097-111. PubMed ID: 22114474
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Solid state characterisation and taste masking efficiency evaluation of polymer based extrudates of isoniazid for paediatric administration.
    Keating AV, Soto J, Tuleu C, Forbes C, Zhao M, Craig DQM.
    Int J Pharm; 2018 Feb 05; 536(2):536-546. PubMed ID: 28687346
    [Abstract] [Full Text] [Related]

  • 37. Crystal growth formation in melt extrudates.
    Bruce C, Fegely KA, Rajabi-Siahboomi AR, McGinity JW.
    Int J Pharm; 2007 Aug 16; 341(1-2):162-72. PubMed ID: 17524578
    [Abstract] [Full Text] [Related]

  • 38. Enhanced Dissolution and Bioavailability of Curcumin Nanocrystals Prepared by Hot Melt Extrusion Technology.
    Zhao Y, Xu X, Dai A, Jia Y, Wang W.
    Int J Nanomedicine; 2024 Aug 16; 19():5721-5737. PubMed ID: 38895153
    [Abstract] [Full Text] [Related]

  • 39. Amorphous-state characterization of efavirenz--polymer hot-melt extrusion systems for dissolution enhancement.
    Sathigari SK, Radhakrishnan VK, Davis VA, Parsons DL, Babu RJ.
    J Pharm Sci; 2012 Sep 16; 101(9):3456-64. PubMed ID: 22437488
    [Abstract] [Full Text] [Related]

  • 40. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.
    Alhijjaj M, Belton P, Qi S.
    Eur J Pharm Biopharm; 2016 Nov 16; 108():111-125. PubMed ID: 27594210
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.